Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I N Todor

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Experimental Oncology|February 22, 2023
BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITEI N Todor, N Yu Lukianova, M A Primin, et al.
Experimental Oncology|October 5, 2018
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing ratsV F Chekhun, D M Storchai, I N Todor, et al.
Experimental Oncology|March 26, 2015
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicinI N Todor, N Yu Lukyanova, Yu V Shvets, et al.
Experimental Oncology|September 30, 2020
Biomagnetism of tumor in rats with Guerin's carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurementI N Todor, N Yu Lukianova, M А Primin, et al.
Experimental Oncology|September 30, 2014
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatinV F Chekhun, Y V Lozovska, A P Burlaka, et al.
Experimental Oncology|October 3, 2013
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatinL A Naleskina, I N Todor, M M Nosko, et al.
Experimental Oncology|January 29, 2011
Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticlesO V Yurchenko, I N Todor, I K Khayetsky, et al.
Experimental Oncology|June 27, 2015
Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factorO O Shevchuk, К А Posokhova, I N Todor, et al.
Tsitologiia I Genetika|June 24, 2006
[Ultrastructural organization of carcinoma Lewis (3LL) cells during cisplatin resistance formation]N A Tregubova, O V Iurchenko, I N Todor, et al.
Experimental Oncology|November 16, 2007
Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistanceO N Pyaskovskaya, O I Dasyukevich, D L Kolesnik, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Experimental Oncology|February 22, 2023
BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITEI N Todor, N Yu Lukianova, M A Primin, et al.
Experimental Oncology|October 5, 2018
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing ratsV F Chekhun, D M Storchai, I N Todor, et al.
Experimental Oncology|March 26, 2015
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicinI N Todor, N Yu Lukyanova, Yu V Shvets, et al.
Experimental Oncology|September 30, 2020
Biomagnetism of tumor in rats with Guerin's carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurementI N Todor, N Yu Lukianova, M А Primin, et al.
Experimental Oncology|September 30, 2014
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatinV F Chekhun, Y V Lozovska, A P Burlaka, et al.
Experimental Oncology|October 3, 2013
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatinL A Naleskina, I N Todor, M M Nosko, et al.
Experimental Oncology|January 29, 2011
Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticlesO V Yurchenko, I N Todor, I K Khayetsky, et al.
Experimental Oncology|June 27, 2015
Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factorO O Shevchuk, К А Posokhova, I N Todor, et al.
Tsitologiia I Genetika|June 24, 2006
[Ultrastructural organization of carcinoma Lewis (3LL) cells during cisplatin resistance formation]N A Tregubova, O V Iurchenko, I N Todor, et al.
Experimental Oncology|November 16, 2007
Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistanceO N Pyaskovskaya, O I Dasyukevich, D L Kolesnik, et al.
Pageof 3